Study
To compare the overnight basal control of glargine (long acting insulin) to the basal control using pump therapy
Type 1 patients equally matched using glargine (8 patients) and pump therapy (11 patients) were studied overnight for 3 days using a Continuous Glucose Monitoring System
To identify overnight differences between treatment regimes, which could not be observed through the use of traditional self blood glucose monitoring